RKLB Rocket Lab Corp
Guided Missiles & Space Vehicles & Parts · Nasdaq · SEC CIK 1819994 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY59.0%
TTM net income YoY-14.8%
TTM EPS YoY2.6%
Revenue 3-yr CAGR55.1%
Net income 3-yr CAGR—
Margins
Gross margin36.2%
Operating margin-27.6%
Net margin-25.7%
FCF margin-36.9%
EBITDA margin-22.2%
Returns
ROE-6.4%
ROA-5.2%
ROIC (approx.)-20.3%
Asset turnover0.20x
Leverage & solvency
Liabilities / assets11.7%
Debt / equity0.00x
Current ratio8.55x
Interest coverage-33.86x
Cash quality & payout
Operating cash flow / net income0.85x
Accruals ratio-0.8%
Payout ratio—
Capex / revenue15.2%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 |
|---|---|---|
| Income statement | ||
| Revenue | $601.80M | $436.21M |
| Cost of revenue | $394.62M | $320.06M |
| Gross profit | $207.18M | $116.15M |
| R&D expense | $270.72M | $174.39M |
| SG&A expense | $165.30M | $131.56M |
| Operating income | -$228.84M | -$189.80M |
| Interest expense | $26.49M | $26.18M |
| Pretax income | -$225.90M | -$189.41M |
| Income tax | -$27.69M | $764,000 |
| Net income | -$198.21M | -$190.18M |
| EBITDA | -$184.90M | -$156.15M |
| EPS (basic) | -0.37 | -0.38 |
| EPS (diluted) | -0.37 | -0.38 |
| Weighted avg. shares (diluted) | 530.66M | 495.93M |
| Balance sheet | ||
| Cash & equivalents | $828.66M | $275.30M |
| Short-term investments | $187.92M | $147.95M |
| Receivables | $39.00M | $36.44M |
| Inventory | $158.41M | $119.07M |
| Current assets | $1.37B | $692.62M |
| PP&E, net | $319.47M | $194.84M |
| Goodwill | $205.75M | $71.02M |
| Intangibles | $224.75M | $58.64M |
| Total assets | $2.32B | $1.18B |
| Current liabilities | $334.48M | $339.52M |
| Short-term debt | $0 | $12.04M |
| Long-term debt | $1.72M | $44.05M |
| Total debt | $1.72M | $56.09M |
| Total liabilities | $602.62M | $801.89M |
| Shareholders' equity | $1.72B | $382.45M |
| Net debt | -$826.94M | -$219.21M |
| Shares outstanding | 543.57M | 504.45M |
| Cash flow statement | ||
| Operating cash flow | -$165.52M | -$48.89M |
| Capital expenditure | $156.28M | $67.09M |
| Free cash flow | -$321.81M | -$115.98M |
| Investing cash flow | -$347.40M | -$98.33M |
| Financing cash flow | $1.07B | $256.68M |
| Depreciation & amortization | $43.94M | $33.66M |
| Stock-based compensation | $71.10M | $56.82M |
Free plan shows the latest 2 periods; Pro shows all 6 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.